T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.53B |
| 2 |
Amazon
AMZN
|
+$1.59B |
| 3 |
Waters Corp
WAT
|
+$1.55B |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$1.17B |
| 5 |
Ascendis Pharma A/S
ASND
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.71B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.54B |
| 3 |
NVIDIA
NVDA
|
+$1.34B |
| 4 |
Amphenol
APH
|
+$1.34B |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 20.39% |
| 3 | Consumer Discretionary | 14.54% |
| 4 | Industrials | 10.59% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
PAR Technology
PAR
$735M
| $34.8M | 0.02% |
2,612,424
-3,304,035
| -56% | -$77.6M |
|
|
BWIN
402
Baldwin Insurance Group
BWIN
$2.86B
| $34.5M | 0.02% |
1,572,803
+417,244
| +36% | +$9.02M |
|
403
Haemonetics
HAE
$4B
| $33.7M | 0.02% |
597,155
-346,030
| -37% | -$22.5M |
|
404
Celanese
CE
$4.82B
| $33.6M | 0.02% |
+511,486
| New | +$26.7M |
|
405
Eagle Bancorp
EGBN
$845M
| $33.5M | 0.02% |
1,346,100
+335,764
| +33% | +$8.37M |
|
406
Douglas Dynamics
PLOW
$1.02B
| $33.2M | 0.02% |
787,967
+2,455
| +0.3% | +$99.1K |
|
407
Shoals Technologies Group
SHLS
$1.5B
| $33.1M | 0.02% |
5,031,902
+636,405
| +14% | +$5.22M |
|
|
SEM
408
DELISTED
Select Medical
SEM
| $33.1M | 0.02% |
2,032,392
-794,595
| -28% | -$12.4M |
|
409
Avalo Therapeutics
AVTX
$983M
| $32.3M | 0.02% |
+2,162,684
| New | +$33.8M |
|
|
AMBQ
410
Ambiq Micro
AMBQ
$1.63B
| $32.2M | 0.02% |
+1,267,551
| New | +$37.8M |
|
411
Gilead Sciences
GILD
$165B
| $32.1M | 0.02% |
230,625
-72,044
| -24% | -$10.1M |
|
412
Hillman Solutions
HLMN
$1.79B
| $32.1M | 0.02% |
3,858,735
+716,152
| +23% | +$6.47M |
|
413
Turning Point Brands
TPB
$1.74B
| $32M | 0.02% |
369,050
-119,783
| -25% | -$13.3M |
|
|
BETA
414
Beta Technologies Inc
BETA
$5.43B
| $31.9M | 0.02% |
2,171,855
+918,868
| +73% | +$18.8M |
|
415
Kodiak Sciences
KOD
$2.84B
| $31.9M | 0.02% |
836,944
+427,818
| +105% | +$11.1M |
|
416
Ponce Financial Group
PDLB
$485M
| $31.8M | 0.02% |
1,905,147
+8,374
| +0.4% | +$138K |
|
417
Alkermes
ALKS
$8.25B
| $31.6M | 0.02% |
894,276
+892,177
| +42,505% | +$27.7M |
|
418
UMB Financial
UMBF
$11.1B
| $31.2M | 0.02% |
277,054
+41,396
| +18% | +$4.98M |
|
419
Impinj
PI
$5.6B
| $30.8M | 0.02% |
300,080
+116,411
| +63% | +$15.5M |
|
420
Personalis
PSNL
$1.51B
| $30.3M | 0.02% |
4,758,091
-6,022,199
| -56% | -$50.8M |
|
421
Peabody Energy
BTU
$2.9B
| $30.1M | 0.02% |
+912,743
| New | +$31.9M |
|
|
HAPN
422
Happen Inc
HAPN
$2.24B
| $29.9M | 0.02% |
2,089,689
+543,651
| +35% | +$9.11M |
|
423
Cabaletta Bio
CABA
$455M
| $29.8M | 0.02% |
11,080,005
+1,221,748
| +12% | +$3.39M |
|
|
NTST
424
NETSTREIT Corp
NTST
$2.1B
| $29.5M | 0.02% |
1,567,632
-650,319
| -29% | -$12.5M |
|
425
Covenant Logistics
CVLG
$872M
| $29M | 0.02% |
1,067,787
+353,271
| +49% | +$9.49M |
|
Similar funds
T. Rowe Price Investment Management's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Investment Management held 968 positions worth $145B, down 8.3% from $158B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
T. Rowe Price Investment Management withdrew a net $7.64B in Q1 2026, closing 325 positions and reducing 267 holdings. Its most notable exit was KKR & Co, an estimated $1.1B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Investment Management opened a new position in Netflix worth $731M.
- T. Rowe Price Investment Management's largest Q1 2026 buy was Netflix: 7,603,053 shares worth $731M.
- T. Rowe Price Investment Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $2.53B increase.
- T. Rowe Price Investment Management's biggest Q1 2026 reduction was Abbott, cutting an estimated $1.71B.
- T. Rowe Price Investment Management fully exited KKR & Co in Q1 2026, selling an estimated $1.1B.
- T. Rowe Price Investment Management's ten largest holdings make up 23% of its $145B portfolio in Q1 2026.
- T. Rowe Price Investment Management opened 71 new positions and closed 325 in Q1 2026.
- T. Rowe Price Investment Management's portfolio value fell 8.3% quarter-over-quarter to $145B.
Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.